Friday, May 14, 2021 11:32:30 AM
Does this sound like a guy who collects a paycheck without adding anything to the conversation?
Described in Chambers USA as having “a remarkable ability to come up with creative solutions,” Jason Sheasby focuses on complex litigation, patents, trade secrets, antitrust, regulatory compliance and internal investigations. His experience spans a wide range of industries, including bio/pharmaceuticals, medical devices, semiconductors, telecommunications, electronics, higher education and healthcare.
As an example of the wide diversity of his practice, in a single year, Jason was hired by a client post-trial to successfully reverse the largest patent verdict in history ($2.5 billion in a medicinal chemistry matter) and also obtained a $400 million jury verdict against the largest semiconductor manufacturer in the world.
In another 12-month period, Jason obtained findings of infringement, validity and willfulness in each of three separate jury trials, with verdicts totaling more than $800 million. In the most recent one, he secured a $500 million verdict against Apple for damages over a period of 19 months in the first patent jury trial of the COVID-19 pandemic. The jury also found that Apple was willful and must pay an ongoing royalty. During this same period, Jason obtained a dismissal with prejudice of a multi-count antitrust and unfair competition complaint that accused his client and others of participating in a cartel and group boycott.
Also on going recognition in the press:
NEWS
Daily Journal Names Morgan Chu, Ben Hattenbach and Jason Sheasby Top IP Lawyers
04.2021
Morgan Chu, Ben Hattenbach and Jason Sheasby were selected to the Daily Journal’s 2021 Top IP Lawyers list, which honors the 80 California attorneys who have made the biggest impact on the intellectual property field.
The publication recognized Morgan for securing a $2.2 billion jury award for VLSI Technology in a trial against Intel, a $1.2 billion patent judgment for Sloan Kettering Institute for Cancer Research and Juno Therapeutics, and a 9-0 U.S. Supreme Court victory for NantKwest. The Daily Journal also noted Ben’s work in obtaining the landmark VLSI verdict, in addition to a confidential settlement for Tessera.
Jason was recognized for victories including a $506.2 million patent trial award for PanOptis against Apple, as well as back-to-back jury verdicts exceeding $300 million for United Services Automobile Association in separate patent trials against Wells Fargo.
Recent NLST News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:00:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2024 04:15:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:00:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 01:37:30 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:02:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 01:00:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 03:00:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/24/2024 08:59:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 01:30:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/15/2024 02:32:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 09:00:29 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2024 08:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 07:01:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 07:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:32:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM